Real-time tumor-tracking proton beam therapy for prostate cancer - Real-time tumor-tracking proton beam therapy for prostate cancer

Department of Radiation Medicine, Hokkaido University Graduate School of Medicine0 个研究点目标入组 45 人开始时间: 2015年2月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Pathologically proven non-adenocarcinoma or mixed type adenocarcinoma of the prostate 2)Clinically obvious lymph node or distant metastasis 3)With active other cancers 4)With severe uncontrolled diabetes 5)With severe heart disease, or some serious complications, i.e., SLE, Scleroderma 6)With an inflammatory bowel syndrome, i.e., Crohn's disease, ulcerative colitis 7)Previous surgical treatment or High-intensity focused ultrasound (HIFU) for prostate 8)Previous chemotherapy for prostate cancer before enrollment 9)Previous surgery to pelvis, except for appendectomy 10)Previous radiotherapy to pelvis 11)With implantable cardioverter defibrillator or permanent pacemaker 12)Allergic to radiation 13)Considered that participation in this trial is difficult because of psychiatric symptoms or psychosis 14)Cannot be held rest for about 30 minutes 15)Cannot be implanted Au marker in the prostate 16)Weight over 135 kg 17)Unsuitable for enrollment judged by principal investigator

发起方

Department of Radiation Medicine, Hokkaido University Graduate School of Medicine